Octagon Capital Advisors LP / APLSUSD
Octagon Capital Advisors LP’s Apellis Pharmaceuticals Inc Position
Does Octagon Capital Advisors LP own Apellis Pharmaceuticals Inc (APLSUSD)? Not currently — the last reported position was 903.5K shares worth $20M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$20M
Q3 2025
Shares
903.5K
% of Portfolio
+3.10%
Quarters Held
20
position exited
Position History APLSUSD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 903.5K | $20M | +3.10% |
| Q2 2025 | 903.5K | $16M | +3.43% |
| Q1 2025 | 2.09M | $46M | +8.86% |
| Q4 2024 | 3.01M | $96M | +15.79% |
| Q3 2024 | 3.01M | $87M | +13.49% |
| Q2 2024 | 2.88M | $111M | +17.37% |
| Q1 2024 | 2.81M | $165M | +19.77% |
| Q4 2023 | 2.81M | $168M | +26.88% |
| Q3 2023 | 3.13M | $119M | +18.29% |
| Q2 2023 | 2.62M | $239M | +33.19% |
| Q1 2023 | 3.25M | $214M | +30.84% |
| Q4 2022 | 3.16M | $163M | +25.44% |
| Q3 2022 | 2.50M | $171M | +29.50% |
| Q2 2022 | 2.58M | $117M | +31.17% |
| Q1 2022 | 2.34M | $119M | +25.70% |
| Q4 2021 | 2.02M | $96M | +18.59% |
| Q3 2021 | 1.60M | $53M | +12.95% |
| Q2 2021 | 1.26M | $79M | +16.44% |
| Q1 2021 | 548.4K | $24M | +8.86% |
| Q4 2020 | 548.4K | $31M | +10.87% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of APLSUSD.